Contact Information
University of Pennsylvania School of Nursing

Philadelphia, Pennsylvania 19104-4217

Publications (select year)
2005  |  2004  |  2003  |  2002  |  2001  |  2000  |  1999  |  1998 and Prior  |  In Press  |  More Publications 

RLS is a disorder that affects up to 15% of the population. It is often misdiagnosed leaving patients with few options for symptom relief. Just recently, the first FDA drug has approved the first phamarcologic agent for the treatment of RLS. This has brought an increased public awareness of RLS, challenging health care providers to learn more about RLS and the sleep disorder that can impact sleep, depression, life satisfaction, quality of life, and other co-morbid chronic health conditions.